Kazakhstan HIV/AIDS Adult Prevalence Rate 2024: 0.30 %
Kazakhstan's hiv/aids adult prevalence rate in 2024 is 0.30 %, unchanged from 2023. It ranks #82 of 148 countries.
HIV/AIDS Adult Prevalence Rate reveals the percentage of adults affected. Compare countries, explore rankings, and view historical trends.
Source (2024): Prevalence of HIV, total (% of population ages 15-49), World Bank (WB)
Where Kazakhstan ranks (2024)
#82 of 148- #82
Greece0.3%
- #82
Italy0.3%
- #82
Kazakhstan0.3%
- #82
Kyrgyzstan0.3%
- #82
Luxembourg0.3%
HIV/AIDS Adult Prevalence Rate over time
| Year | Value | Change | % Change | Actions |
|---|---|---|---|---|
| 2024 | 0.3 % | 0 % | 0.00% | |
| 2023 | 0.3 % | 0 % | 0.00% | |
| 2022 | 0.3 % | 0 % | 0.00% | |
| 2021 | 0.3 % | 0 % | 0.00% | |
| 2020 | 0.3 % | 0 % | 0.00% | |
| 2019 | 0.3 % | 0 % | 0.00% | |
| 2018 | 0.3 % | 0 % | 0.00% | |
| 2017 | 0.3 % | 0 % | 0.00% | |
| 2016 | 0.3 % | +0.1 % | +50.00% | |
| 2015 | 0.2 % | 0 % | 0.00% | |
| 2014 | 0.2 % | 0 % | 0.00% | |
| 2013 | 0.2 % | 0 % | 0.00% | |
| 2012 | 0.2 % | 0 % | 0.00% | |
| 2011 | 0.2 % | +0.1 % | +100.00% | |
| 2010 | 0.1 % | 0 % | 0.00% | |
| 2009 | 0.1 % | 0 % | 0.00% | |
| 2008 | 0.1 % | 0 % | 0.00% | |
| 2007 | 0.1 % | 0 % | 0.00% | |
| 2006 | 0.1 % | 0 % | 0.00% | |
| 2005 | 0.1 % | 0 % | 0.00% | |
| 2004 | 0.1 % | 0 % | 0.00% | |
| 2003 | 0.1 % | 0 % | 0.00% | |
| 2002 | 0.1 % | 0 % | 0.00% | |
| 2001 | 0.1 % | 0 % | 0.00% | |
| 2000 | 0.1 % | 0 % | 0.00% | |
| 1999 | 0.1 % | 0 % | 0.00% | |
| 1998 | 0.1 % | 0 % | 0.00% | |
| 1997 | 0.1 % | 0 % | 0.00% | |
| 1996 | 0.1 % | 0 % | 0.00% | |
| 1995 | 0.1 % | 0 % | 0.00% | |
| 1994 | 0.1 % | 0 % | 0.00% | |
| 1993 | 0.1 % | 0 % | 0.00% | |
| 1992 | 0.1 % | 0 % | 0.00% | |
| 1991 | 0.1 % | 0 % | 0.00% | |
| 1990 | 0.1 % | — | — |
Cite this page
Geo Factbook. (n.d.). Kazakhstan: HIV/AIDS Adult Prevalence Rate. Retrieved November 20, 2026, from https://geofactbook.com/countries/kazakhstan/hivaids-adult-prevalence-rate
The figures on this page come from Prevalence of HIV, total (% of population ages 15-49) | UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS) via World Bank. For academic work, cite the original source as well.
Frequently Asked Questions About Kazakhstan HIV/AIDS Adult Prevalence Rate
What is Kazakhstan's hiv/aids adult prevalence rate in 2024?▾
Kazakhstan's hiv/aids adult prevalence rate is 0.30 % in 2024, according to Prevalence of HIV, total (% of population ages 15-49) | UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS) via World Bank.
Is Kazakhstan's hiv/aids adult prevalence rate increasing or decreasing?▾
Kazakhstan's hiv/aids adult prevalence rate was essentially unchanged from 2023 (0.30 %) to 2024 (0.30 %). Over the past decade (2014–2024) it rose by 50.0%.
How does Kazakhstan rank for hiv/aids adult prevalence rate?▾
In 2024, Kazakhstan has the 82nd highest hiv/aids adult prevalence rate out of 148 countries with data.
What was Kazakhstan's hiv/aids adult prevalence rate in 1990?▾
In 1990, Kazakhstan's hiv/aids adult prevalence rate was 0.10 %. By 2024 it rose by 200.0%.
Explore additional statistical insights
Women Tobacco Use by Age Group in Kazakhstan
Women tobacco use by age group; compare age-specific smoking and tobacco habits among females globally.
Health Care Spending per Capita in Kazakhstan
Health care spending per capita measures the average health expenditure per person in a country, highlighting affordability.
Cancer Mortality Rate in Kazakhstan
Cancer mortality rate measures the number of cancer deaths per 100,000 people annually; crucial for health strategy assessment.
Pancreatic Cancer Mortality Rate in Kazakhstan
Pancreatic cancer mortality rate shows how many die from this cancer per 100,000 people annually. High rates help identify at-risk populations.
Hospital Beds per Capita in Kazakhstan
Hospital beds per capita highlights healthcare infrastructure by showing available hospital beds per 1,000 people globally.
Out-of-Pocket Health Spending in Kazakhstan
Out-of-pocket health spending measures the personal financial burden of healthcare costs in different countries.